Houlihan Lokey Advises Keensight Capital

Houlihan Lokey is pleased to announce that Keensight Capital (Keensight), a leading global private equity firm, has invested a minority stake in Bentley Innomed (Bentley).

Bentley was founded in 2009 by medical entrepreneurs Lars Sunnanvader and Miko Obradovic and is a leading MedTech company with a strongly positioned portfolio of cardiovascular stents, catheters, and adjacent solutions for minimally invasive and interventional vascular therapies. The company has seen substantial growth since the launch of its first product in 2012, and today, it operates a global distribution network in more than 70 countries.

Keensight has signed an agreement to acquire a minority stake in Bentley from existing shareholders alongside co-investors. Post-transaction, the current owner will remain the largest shareholder group. The new growth partnership with Keensight will further accelerate Bentley’s growth trajectory and cement positioning for its planned IPO.

Houlihan Lokey served as the exclusive financial advisor to Keensight, a European growth buyout investor with deep expertise in technology and healthcare. The company partners with management teams of fast-growing and profitable companies that provide capital, strategic guidance, and operational support. The transaction highlights Houlihan Lokey’s continued success advising clients in the MedTech and private capital sectors.